Latest period
$525.60M
YoY change
+45.6%
5Y CAGR
+24.8%
Peak year (2025)
$1.44B
Latest annual
$1.44B
Operating Cash Flow history chart for DexCom (DXCM) from 2003 to 2025
Latest: $1.44B
Operating Cash Flow growth chart for DexCom (DXCM) from 2003 to 2025
Latest: +45.6%
Operating Cash Flow history table for DexCom (DXCM) from 2003 to 2025
| 2025 | $1.44B | +45.6% | +$451.20M | ||
| 2024 | $989.50M | +32.2% | +$241.00M | ||
| 2023 | $748.50M | +11.8% | +$79.00M | ||
| 2022 | $669.50M | +51.3% | +$227.00M | ||
| 2021 | $442.50M | -7.0% | −$33.10M | ||
| 2020 | $475.60M | +51.2% | +$161.10M | ||
| 2019 | $314.50M | +155.3% | +$191.30M | ||
| 2018 | $123.20M | +33.9% | +$31.20M | ||
| 2017 | $92.00M | +63.7% | +$35.80M | ||
| 2016 | $56.20M | +14.7% | +$7.20M | ||
| 2015 | $49.00M | +107.6% | +$25.40M | ||
| 2014 | $23.60M | +883.3% | +$21.20M | ||
| 2013 | $2.40M | -107.3% | +$35.50M | ||
| 2012 | −$33.10M | +9.9% | −$2.97M | ||
| 2011 | −$30.13M | -29.4% | +$12.55M | ||
| 2010 | −$42.68M | +8.3% | −$3.29M | ||
| 2009 | −$39.39M | +5.2% | −$1.94M | ||
| 2008 | −$37.45M | +12.8% | −$4.24M | ||
| 2007 | −$33.21M | -24.1% | +$10.53M | ||
| 2006 | −$43.73M | +93.9% | −$21.18M | ||
| 2005 | −$22.55M | +81.5% | −$10.13M | ||
| 2004 | −$12.43M | +31.4% | −$2.97M | ||
| 2003 | −$9.46M | — | — |
- 2025$1.44B+45.6%
- 2024$989.50M+32.2%
- 2023$748.50M+11.8%
- 2022$669.50M+51.3%
- 2021$442.50M-7.0%
- 2020$475.60M+51.2%
- 2019$314.50M+155.3%
- 2018$123.20M+33.9%
- 2017$92.00M+63.7%
- 2016$56.20M+14.7%
- 2015$49.00M+107.6%
- 2014$23.60M+883.3%
- 2013$2.40M-107.3%
- 2012−$33.10M+9.9%
- 2011−$30.13M-29.4%
- 2010−$42.68M+8.3%
- 2009−$39.39M+5.2%
- 2008−$37.45M+12.8%
- 2007−$33.21M-24.1%
- 2006−$43.73M+93.9%
- 2005−$22.55M+81.5%
- 2004−$12.43M+31.4%
- 2003−$9.46M—
Operating Cash Flow values are taken from DexCom's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at DexCom (DXCM)
Operating Cash Flow for DexCom (DXCM): headline value $525.60M · YoY +45.6%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of DexCom (DXCM) operating cash flow is $1.44B – surged 45.6% year-over-year.
Looking at the 2020–2025 (5 years) stretch, DexCom operating cash flow compounded at +24.8% per year, sustaining 4 straight years of year-over-year growth.
$1.44B stands as the all-time-high annual operating cash flow, posted in 2025, against a low of −$43.73M during 2006.
DexCom Operating Cash Flow by Year
DexCom Operating Cash Flow 2025: $1.44B
2025's operating cash flow for DexCom came in at $1.44B, surged 45.6% from 2024. This figure represents the highest annual value in the available history.
DexCom Operating Cash Flow 2024: $989.50M
DexCom posted operating cash flow of $989.50M in 2024, surged 32.2% from 2023.
DexCom Operating Cash Flow 2023: $748.50M
In 2023, DexCom reported operating cash flow of $748.50M, grew 11.8% from 2022.
DexCom Operating Cash Flow 2022: $669.50M
DexCom operating cash flow in 2022 was $669.50M, surged 51.3% from 2021.
DexCom Operating Cash Flow 2021: $442.50M
DexCom operating cash flow in 2021 was $442.50M.
See more financial history for DexCom (DXCM).
Sector peers by Operating Cash Flow
Healthcare peers of DexCom (DXCM), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $16.47B | |
| $14.57B | |
| $9.96B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation